Proceeds Used to Acquire ClinEdge and Invest Further in Technology & Data Platform SAN FRANCISCO–(BUSINESS WIRE)– Morgan Stanley Expansion Capital and Ally Bridge Group,… Read More
First Indication for Lead TREM2 Agonist Program Announced as Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Financing Led by Vida Ventures; Stefan… Read More
MINNEAPOLIS, June 29, 2021 (GLOBE NEWSWIRE) — CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally… Read More
Industry Veterans Join Team to Support the Development of Novel Cyclic Aspiration System for Ischemic Stroke MIAMI, June 23, 2021 (GLOBE NEWSWIRE) — RapidPulse,… Read More
FREDERICK, Md., June 16, 2021 /PRNewswire/ — Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant… Read More
CINCINNATI, June 1, 2021 /PRNewswire/ — Cincinnati-based Standard Bariatrics, Inc., has developed the Titan SGS™, a first-of-its-kind design that offers surgeons performing sleeve… Read More
Congratulations to our esteemed Hatteras Venture Partners colleague Bob Ingram on his recognition for the Business NC Power List for Finance and Insurance 2021. Read More
The combined Company will provide full-service CRO services to meet needs of global fast-moving biotech, pharma and medical device companies, and to accelerate the delivery… Read More
Agreement enables Biohaven to exercise option on up to three of Artizan’s candidates for the treatment of inflammatory bowel disease… Read More
– COSELA is the only FDA-approved therapy that helps proactively deliver multilineage myeloprotection to patients with extensive-stage small cell lung cancer being treated with chemotherapy –… Read More